Kotak Healthcare Fund - Regular Plan - IDCW Option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 11-12-2023
AUM:
₹ 485.27 Cr
Expense Ratio
2.4%
Benchmark
NIFTY Healthcare TRI
ISIN
INF174KA1PX2
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
100
Fund Manager
FM 1 Ms. Shibani Kurian, FM 2 Mr. Dhananjay Tikariha, FM 3 Mr. Abhishek Bisen
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Kotak Healthcare Fund - Regular Plan - IDCW Option | 6.49 | - | - |
| NIFTY Healthcare TRI | 6.94 | 22.63 | 17.46 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
13.604
Last change
-0.05 (-0.3969%)
Fund Size (AUM)
₹ 485.27 Cr
Performance
20.14% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Fund Manager
FM 1 Ms. Shibani Kurian, FM 2 Mr. Dhananjay Tikariha, FM 3 Mr. Abhishek Bisen
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 14.07 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 7.83 |
| JB Chemicals & Pharmaceuticals Limited | 5.87 |
| Triparty Repo | 5.85 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.44 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.81 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 4.09 |
| JUBILANT PHARMOVA LIMITED EQ NEW FV RE.1/- | 3.44 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.18 |
| GLAND PHARMA LIMITED EQ NEW FV Re.1/- | 2.98 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 94.41 |